Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Get in touch with us now| Characteristic | Expenses in millions of euros |
|---|---|
| - | - |
| - | - |
| - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
Sources
Release date
June 2023
More information
Region
France
Survey time period
2021
Special properties
expenditures extrapolated to all schemes and aligned with the ONDAM (National Objective for Health Insurance Expenditures)
Supplementary notes
The source adds the following information: "Algorithm for defining the pathology: Persons with a Long-Term Condition (ALD) during year n with ICD-10 codes for dementias, and/or persons who received at least 3 dispensations of medications from ATC (Anatomical Therapeutic Chemical) classes N06DA and N06DX01 (updated January 27, 2015) during year n (on different dates), and/or persons who received at least 3 dispensations of medications from classes N06DA, N06DX01 (updated January 27, 2015) during year n-1 (on different dates), and/or persons hospitalized for Alzheimer's disease or other dementias during years n to n-4 (principal diagnosis (PD) or related diagnosis (RD) from PMSI-MCO), and/or persons hospitalized during year n for any other reason with dementia as a complication or associated morbidity (associated diagnosis (AD) from PMSI-MCO), and/or persons hospitalized for Alzheimer's disease or other dementias during years n to n-4 (PD from RIM-P) (excluding dementia related to HIV infection and Parkinson's disease)." and "includes persons with missing age." * daily sickness benefits, work accident/occupational disease, maternity, and disability
Citation formats
